525 related articles for article (PubMed ID: 25302802)
1. Intranasal delivery of bone marrow-derived mesenchymal stem cells, macrophages, and microglia to the brain in mouse models of Alzheimer's and Parkinson's disease.
Danielyan L; Beer-Hammer S; Stolzing A; Schäfer R; Siegel G; Fabian C; Kahle P; Biedermann T; Lourhmati A; Buadze M; Novakovic A; Proksch B; Gleiter CH; Frey WH; Schwab M
Cell Transplant; 2014; 23 Suppl 1():S123-39. PubMed ID: 25302802
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic efficacy of intranasally delivered mesenchymal stem cells in a rat model of Parkinson disease.
Danielyan L; Schäfer R; von Ameln-Mayerhofer A; Bernhard F; Verleysdonk S; Buadze M; Lourhmati A; Klopfer T; Schaumann F; Schmid B; Koehle C; Proksch B; Weissert R; Reichardt HM; van den Brandt J; Buniatian GH; Schwab M; Gleiter CH; Frey WH
Rejuvenation Res; 2011 Feb; 14(1):3-16. PubMed ID: 21291297
[TBL] [Abstract][Full Text] [Related]
3. Intracerebral transplantation of adipose-derived mesenchymal stem cells alternatively activates microglia and ameliorates neuropathological deficits in Alzheimer's disease mice.
Ma T; Gong K; Ao Q; Yan Y; Song B; Huang H; Zhang X; Gong Y
Cell Transplant; 2013; 22 Suppl 1():S113-26. PubMed ID: 24070198
[TBL] [Abstract][Full Text] [Related]
4. Distribution pattern following systemic mesenchymal stem cell injection depends on the age of the recipient and neuronal health.
Fabian C; Naaldijk Y; Leovsky C; Johnson AA; Rudolph L; Jaeger C; Arnold K; Stolzing A
Stem Cell Res Ther; 2017 Apr; 8(1):85. PubMed ID: 28420415
[TBL] [Abstract][Full Text] [Related]
5. Transplantation of porcine umbilical cord matrix mesenchymal stem cells in a mouse model of Parkinson's disease.
Kang EJ; Lee YH; Kim MJ; Lee YM; Kumar BM; Jeon BG; Ock SA; Kim HJ; Rho GJ
J Tissue Eng Regen Med; 2013 Mar; 7(3):169-82. PubMed ID: 22081626
[TBL] [Abstract][Full Text] [Related]
6. In vitro validation of effects of BDNF-expressing mesenchymal stem cells on neurodegeneration in primary cultured neurons of APP/PS1 mice.
Song MS; Learman CR; Ahn KC; Baker GB; Kippe J; Field EM; Dunbar GL
Neuroscience; 2015 Oct; 307():37-50. PubMed ID: 26297896
[TBL] [Abstract][Full Text] [Related]
7. Bone-marrow-derived cell differentiation into microglia: a study in a progressive mouse model of Parkinson's disease.
Rodriguez M; Alvarez-Erviti L; Blesa FJ; Rodríguez-Oroz MC; Arina A; Melero I; Ramos LI; Obeso JA
Neurobiol Dis; 2007 Dec; 28(3):316-25. PubMed ID: 17897835
[TBL] [Abstract][Full Text] [Related]
8. Bone marrow-derived mesenchymal stem cells reduce brain amyloid-beta deposition and accelerate the activation of microglia in an acutely induced Alzheimer's disease mouse model.
Lee JK; Jin HK; Bae JS
Neurosci Lett; 2009 Jan; 450(2):136-41. PubMed ID: 19084047
[TBL] [Abstract][Full Text] [Related]
9. Potential of bone marrow mesenchymal stem cells in management of Alzheimer's disease in female rats.
Salem AM; Ahmed HH; Atta HM; Ghazy MA; Aglan HA
Cell Biol Int; 2014 Dec; 38(12):1367-83. PubMed ID: 25044885
[TBL] [Abstract][Full Text] [Related]
10. The effect of focal brain injury on beta-amyloid plaque deposition, inflammation and synapses in the APP/PS1 mouse model of Alzheimer's disease.
Collins JM; King AE; Woodhouse A; Kirkcaldie MT; Vickers JC
Exp Neurol; 2015 May; 267():219-29. PubMed ID: 25747037
[TBL] [Abstract][Full Text] [Related]
11. Soluble CCL5 derived from bone marrow-derived mesenchymal stem cells and activated by amyloid β ameliorates Alzheimer's disease in mice by recruiting bone marrow-induced microglia immune responses.
Lee JK; Schuchman EH; Jin HK; Bae JS
Stem Cells; 2012 Jul; 30(7):1544-55. PubMed ID: 22570192
[TBL] [Abstract][Full Text] [Related]
12. Bone marrow-derived mesenchymal stem cells contribute to the reduction of amyloid-β deposits and the improvement of synaptic transmission in a mouse model of pre-dementia Alzheimer's disease.
Bae JS; Jin HK; Lee JK; Richardson JC; Carter JE
Curr Alzheimer Res; 2013 Jun; 10(5):524-31. PubMed ID: 23036020
[TBL] [Abstract][Full Text] [Related]
13. Intracerebral transplantation of bone marrow-derived mesenchymal stem cells reduces amyloid-beta deposition and rescues memory deficits in Alzheimer's disease mice by modulation of immune responses.
Lee JK; Jin HK; Endo S; Schuchman EH; Carter JE; Bae JS
Stem Cells; 2010 Feb; 28(2):329-43. PubMed ID: 20014009
[TBL] [Abstract][Full Text] [Related]
14. Delayed intranasal delivery of hypoxic-preconditioned bone marrow mesenchymal stem cells enhanced cell homing and therapeutic benefits after ischemic stroke in mice.
Wei N; Yu SP; Gu X; Taylor TM; Song D; Liu XF; Wei L
Cell Transplant; 2013; 22(6):977-91. PubMed ID: 23031629
[TBL] [Abstract][Full Text] [Related]
15. Intranasal Administration of Mesenchymal Stem Cells Ameliorates the Abnormal Dopamine Transmission System and Inflammatory Reaction in the R6/2 Mouse Model of Huntington Disease.
Yu-Taeger L; Stricker-Shaver J; Arnold K; Bambynek-Dziuk P; Novati A; Singer E; Lourhmati A; Fabian C; Magg J; Riess O; Schwab M; Stolzing A; Danielyan L; Nguyen HHP
Cells; 2019 Jun; 8(6):. PubMed ID: 31208073
[TBL] [Abstract][Full Text] [Related]
16. Bone-marrow-derived cells contribute to the recruitment of microglial cells in response to beta-amyloid deposition in APP/PS1 double transgenic Alzheimer mice.
Malm TM; Koistinaho M; Pärepalo M; Vatanen T; Ooka A; Karlsson S; Koistinaho J
Neurobiol Dis; 2005 Feb; 18(1):134-42. PubMed ID: 15649704
[TBL] [Abstract][Full Text] [Related]
17. Myeloid differentiation factor 88-deficient bone marrow cells improve Alzheimer's disease-related symptoms and pathology.
Hao W; Liu Y; Liu S; Walter S; Grimm MO; Kiliaan AJ; Penke B; Hartmann T; Rübe CE; Menger MD; Fassbender K
Brain; 2011 Jan; 134(Pt 1):278-92. PubMed ID: 21115468
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of the mesenchymal stem cell Cxcr4 gene in irradiated mice increases the homing capacity of these cells.
Chen W; Li M; Cheng H; Yan Z; Cao J; Pan B; Sang W; Wu Q; Zeng L; Li Z; Xu K
Cell Biochem Biophys; 2013; 67(3):1181-91. PubMed ID: 23712865
[TBL] [Abstract][Full Text] [Related]
19. Migration of bone marrow-derived cells into the central nervous system in models of neurodegeneration.
Lampron A; Pimentel-Coelho PM; Rivest S
J Comp Neurol; 2013 Dec; 521(17):3863-76. PubMed ID: 23682015
[TBL] [Abstract][Full Text] [Related]
20. Minocycline reduces engraftment and activation of bone marrow-derived cells but sustains their phagocytic activity in a mouse model of Alzheimer's disease.
Malm TM; Magga J; Kuh GF; Vatanen T; Koistinaho M; Koistinaho J
Glia; 2008 Dec; 56(16):1767-79. PubMed ID: 18649403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
